Pressure BioSciences, Inc.
PBIO · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $6,180 | $6,768 | $7,434 | $4,235 |
| - Cash | $14 | $3 | $81 | $5 |
| + Debt | $29,194 | $27,098 | $22,886 | $18,522 |
| Enterprise Value | $35,359 | $33,863 | $30,239 | $22,752 |
| Revenue | $422 | $349 | $312 | $413 |
| % Growth | 20.8% | 11.8% | -24.4% | – |
| Gross Profit | $44 | $116 | -$21 | -$229 |
| % Margin | 10.5% | 33.2% | -6.8% | -55.6% |
| EBITDA | -$3,492 | -$2,614 | -$3,463 | -$1,263 |
| % Margin | -827.9% | -748.3% | -1,108.7% | -305.8% |
| Net Income | -$7,116 | -$8,074 | -$9,904 | -$6,262 |
| % Margin | -1,687.2% | -2,311.9% | -3,170.7% | -1,516.2% |
| EPS Diluted | -0.15 | -0.22 | -0.44 | -0.288 |
| % Growth | 31.8% | 50% | -52.6% | – |
| Operating Cash Flow | -$706 | -$1,860 | -$1,132 | -$732 |
| Capital Expenditures | $0 | $0 | -$7,488 | -$4 |
| Free Cash Flow | -$706 | -$1,860 | -$8,620 | -$737 |